Research Article
Neuroprotective Effects of OMO within the Hippocampus and Cortex in a D-Galactose and Aβ25–35-Induced Rat Model of Alzheimer’s Disease
Figure 10
Effect of OMO on the monoamine neurotransmitter levels in the hippocampus of D-galactose and Aβ25–35-treated AD rats. The graphs show levels of (a) NE, (b) E, (c) DA, (d) 5-HT, (e) L-DOPA, (f) DOPAC, (g) 5-HIAA, and (h) HVA. These values are expressed as mean ± SD, n = 8. , , compared with the normal control group; and compared with the model group.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |